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	 Erythrina	 indica	 commonly	 known	 as	 Coral	 tree	 has	 been	widely	 used	 in	 Indian	 traditional
medicine	 for	 treating	 common	 ailments	 such	 as	 asthma,	 arthritis,	 diarrhoea,	 fever,
inflammation	 and	 leprosy.	 Certain	 phytochemical	 constituents	 such	 as:	 alkaloids,	 aliphatic
fatty	 acids,	 alkaloids	have	also	been	 reported.	A	wide	 range	of	medicinal	 formulations	have
been	developed	from	E.	 indica	 that	exhibit	analgesic,	antiarthritic,	anti‐hypertriglyceridemia,
anti‐inflammatory	 and	 muscle	 relaxing	 effects.	 This	 review	 summarizes	 the	 phytochemical
investigations	and	pharmacological	activities	of	E.	indica.	
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1.	Introduction	
	
The	genus	Erythrina	(Leguminosae)	which	is	distributed	in	
the	 tropical	 and	 subtropical	 regions	 comprises	 of	
approximately	 110	 species	 [1,2].	 Some	 of	 the	 species	 of	 this	
genus	are	a	rich	source	of	alkaloids	and	flavonoids,	and	certain	
species	 are	 used	 in	 traditional	 medicine	 for	 the	 treatment	 of	
several	diseases	[3‐6].	
Erythrina	 indica	 (Coral	 tree)	 which	 is	 found	 in	 the	 wild	
tropics	and	deciduous	forests	of	India,	grows	to	a	height	of	18	
m,	possess	a	thin,	smooth	and	grey	bark	with	small	conical	dark	
coloured	 prickles.	 E.	 indica	 bark	 is	 used	 medicinally	 as	
febrifuge,	 anti‐bilious,	 antidiarrhoeal	 and	 antirheumatic,	 the	
bark	 has	 also	 been	 used	 in	 the	 treatment	 of	 asthma,	 burning	
sensation,	 itching,	 fever	 and	 leprosy.	 Its	 leaves	 are	 15‐30	 cm	
long	 and	 are	 used	 to	 improve	 appetite	 and	 urinary	 discharge	
inflammation.	 Traditionally,	 the	 leaves	 are	 known	 to	 possess	
analgesic,	 anthelmintic,	 antiulcer	 and	 sedative	 properties.	
Extracts	of	the	leaves	have	been	employd	to	treat	liver,	diuretic,	
dysentery	and	joint	pain	[7‐13].	
	
2.	Phytochemical	investigations	with	bio‐activity	
	
There	 have	 been	 very	 few	 phytochemical	 investigations	
with	bioactivity	on	E.	indica,	and	most	of	the	studies	have	been	
done	 on	 the	 bark.	 Examinations	 of	 the	 root	 bark	 of	 E.	 indica	
indicated	the	presence	of	a	new	3‐phenylcoumarin,	 indicanine	
A	(1)	(Scheme	1),	along	with	three	known	compounds	robustic	
acid,	daidzein,	and	8‐prenyldaidzein.	The	 isolated	constituents	
were	 examined	 for	 in	 vitro	 antibacterial	 activity,	 however,	 no	
potent	 activity	was	 observed	 for	 any	 of	 the	 compounds	 [14].	
Waffo	et	al.,	 reported	 from	the	 root	bark	of	E.	 indica	 two	new	
componds	 a	 3‐phenylcoumarin	 metabolite,	 indicanine	 B	 (2)	
and	 an	 isoflavone	 derivative	 indicanine	 C	 (3).	 The	 isolated	
compounds	indicated	potent	antimicrobial	activities	[15].		
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Scheme	1		
	
	
Bio‐guided	 isolations	 of	 the	 CH2Cl2‐MeOH	 (1:1)	 extract	 of	
the	 stem	 bark	 of	 E.	 indica,	 yielded	 two	 new	 compounds	
indicanines	D	 (4)	 (Scheme	2)	and	E	 (5)	along	with	11	known	
compounds	genistein,	wighteone,	alpinumisoflavone,	dimethyl‐
alpinumisoflavone,	 8‐prenylerythrinin	 C,	 erysenegalensein	 E,	
erythrinassinate	B,	oleanolic	acid,	erythrodiol,	stigmasterol	and	
stigmasterol	 3‐O‐β‐D‐glucopyranoside).	 Potent	 in	 vitro	 cyto‐
toxic	 activity	 against	 KB	 cells	 was	 observed	 for	 the	 isolated	
compounds	[2].			
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(5)	
	
Scheme	2	
	
Nassar	et	al.,	isolated	from	the	ethanol	extract	of	the	leaves	
of	 E.	 indica	 a	 new	 gentisic	 acid	 glycoside,	 5‐O‐β‐D‐xylo‐
pyranoside	(6)	(Scheme	3),	along	with	seven	known	flavone	C‐
glycosides	 isovitexin,	 vitexin,	 vicenin	 2,	 apigenin	 6‐C‐α‐L‐
rhamnopyranoside,	 orientin,	 isoorientin	 and	 luteolin	 6,8‐di‐C‐
α‐L‐rhamnopyranoside.	The	ethanol	extract	of	E.	 indica	 leaves	
also	exhibited	strong	antioxidant	activity	[16].			
	
	
(6)	
	
Scheme	3 
	
3.	Phytochemical	investigations	
	
Phytochemical	 investigations	of	E.	 indica	are	mostly	based	
on	the	compositions	of	the	particular	components	and	a	limited	
number	of	phytochemicals	have	been	reported.	
Examinations	 of	 the	 seeds	 of	 E.	 indica	 indicated	 the	
presence	 of	 an	 oil	 (11.9%,	 yield)	 exhibiting	 unsaponifiable	
matter	 0.49%.	 	 The	 oil	 contained	 behenic,	 arachidic,	 palmitic	
and	 lignoceric,	 oleic	 and	 linoleic	 acids	 [17].	 Extraction	 of	 the	
seeds	of	E.	indica	with	petroleum	ether	produced	a	yellow	fatty	
oil	(11.3%)	yield.	 	The	saponification	of	the	oil	gave	a	mixture	
of	36.7%	saturated	and	63.3%	unsaturated	acids.	The	saturated	
acids	 were	 found	 to	 contain	 oleic	 84.4%	 and	 linoleic	 acids	
15.6%.	 Further	 investigations	 of	 the	 ethanol	 extract	 of	 the	
seeds	produced	a	compound	hypaphorine	[18].	
A	comparative	study	of	the	seeds	of	the	two	white	and	red	
varieties	 of	 E.	 indica	 was	 conducted	 by	 extracting	 the	 seeds	
with	 petroleum	 ether	 to	 obtain	 the	 oils.	 The	 white	 variety	
yielded	 12%	 of	 a	 reddish	 fixed	 oil	 having	 a	 specific	 gravity	
0.8603	at	30ºC	and	the	oil	extracted	from	the	red	variety	of	E.	
indica,	 had	 a	 specific	 gravity	 0.8821	 at	 30	 oC	 the	 alcoholic	
extract	of	the	oil‐free	seeds	of	the	white	variety	yielded	a	white	
crystalline	 alkaloid	 nitrate,	 identical	 to	 hypaphorine	 nitrate	
isolated	from	the	seeds	of	the	red	variety	[19].	
The	examination	of	the	acid	components	of	the	seeds	of	E.	
indica	 revelaed	 the	 presence	 of	 palmitic	 8.2%,	 stearic	 8.0%,	
arachidic	 4.3%,	 behenic	 13.3%,	 hexadecenoic	 3.1%,	 oleic,	
45.6%,	linoleic	7.1%,	eicosenoic	9.8%,	and	lignoceric	0.6%	[20].	
Investigations	of	the	seeds	of	E.	indica,	suggested	the	presence	
of	hypaphorine	[11].	
Kartha	and	Narayanan,	examined	the	glyceride	structure	of	
E.	 indica	 seed	 fat	by	azelao‐glyceride	analysis	 techniques.	The	
amount	 of	 saturated	 acids	 was	 found	 to	 be	 34	 mole	 %	 and	
trisaturated	 glycerides	 were	 not	 detected.	 The	 triglycerides	
were	 observed	 to	 be	 composed	 of	 disaturated	 27.1,	
monosaturated	48.3	and	triunsaturated	glycerides	24.6	mole	%	
[21].	
Pant	and	Tulsiani,	reported	the	total	soluble	carbohydrates	
in	 seeds	 of	 five	 plants	 including	 E.	 indica	 to	 be	 12.02‐22.98	
grams	of	glucose/100	grams	of	seed.	Total	reducing	substances	
were	 2.35‐5.32	 grams	 of	 glucose/100	 grams	 of	 seed.	 All	 the	
edible	 seed	 species	 including	 E.	 indica	 appeared	 to	 be	
adequately	 nutritious	 sources	 of	 proteins,	 carbohydrates,	 and	
minerals	 [22].	 Studies	 of	 the	 physicochemical	 composition	 of	
certain	 seed	 plants	 including	E.	 indica,	 revealed	 the	 following	
compositions:	 mineral	 elements	 (2.1‐8.0%),	 protein	 (9.1‐
26.5%),	cellulose	(5.8‐28.4%),	and	lipid	(0.4‐29.7%)	[23].	
Yadava	 and	 Reddy,	 isoalted	 a	 novel	 prenylated	 flavone	
glycoside	 5,7,4'‐trihydroxy‐3'‐methoxy‐8‐C‐prenylflavone	 7‐O‐
β‐D‐glucopyranosyl‐(1→3)‐α‐L‐arabinopyranoside	(7)	(Scheme	
4)	was	isolated	from	the	seeds	of	E.	indica	[24].			
	
	
(7)	
	
Scheme	4 
	
Singh	et	al.,	 isolated	from	the	water	soluble	sugar	extracts	
of	 E.	 indica	 seeds,	 D‐galactose	 and	 D‐mannose	 in	 2:3	 molar	
ratio.	 	The	methyl	sugars	afforded	2,	3,	4,	6‐tetra‐O‐methyl‐D‐
galactose;	2,	3,	4‐tri‐O‐methyl‐D‐galactose;	2,	3,	6‐tri‐O‐methyl‐
D‐mannose	and	2,	3‐di‐O‐methyl‐D‐mannose	in	1:	1:	2:	1	molar	
ratios,	 respectively.	 Furthermore,	 the	 water	 soluble	 sugar	
solutions	(D‐galactose	and	D‐mannose	in	2:	3	molar	ratio)	were	
isolated	 from	E.	 Indica	 seeds	 by	 graded	 hydrolytic	 studies.	 It	
yielded	 three	 disaccharides	 α‐D‐galactopyranosyl‐(1→6)‐O‐α‐
D‐galactopyranose,	 α‐D‐galactopyranosyl‐(1→6)‐O‐α‐D‐man‐
nopyranose	 and	 β‐D‐mannopyranosyl‐(1→4)‐O‐β‐D‐manno‐
pyranose	and	 two	 trisaccharides	α‐D‐galactopyranosyl‐(1→6)‐
O‐α‐galactopyranosyl‐(1→6)‐O‐α‐mannopyranose	 and	 β‐D‐
mannopyranosyl‐(1→4)‐O‐β‐D‐mannopyranosyl‐(1→4)‐O‐β‐D‐
mannopyranose	by	graded	hydrolytic	studies	[25,26].	
Chakravarti	 et	 al..	 examined	 the	 leaves	 of	 E.	 indica	 and	
indicated	 the	 presence	 of	 a	 white	 solid	 which	 was	 not	 a	
phytosterol	or	glucoside	and	an	alkaloid.	Further	investigations	
of	 the	 leaves	 of	 E.	 indica	 indicated	 the	 presence	 of	 a	 new	
compound	 erythrinine	 (8)	 (Scheme	 5)	 along	 with	 erysodine	
and	de‐N‐methylorientaline	[27,28].	
	
	
(8)	
	
Scheme	5 
	
Investigations	 of	 the	 bark	 of	 E.	 indica	 indicated	 the	
presence	of	fixed	oils	and	an	inert	alkaloid	which	decomposes	
at	97	oC	[29].	Further	investigations	of	the	alcoholic	extract	of	E.	
indica	 bark	 indicated	 the	 presence	 of	 docosyl	 alcohol,	 β‐
sitosterol,	γ‐sitosterol,	δ‐sitosterol,	and	2,4‐dinitrophenyl‐
hydrazone	[30].	
	
4.	Lectin	based	studies	
	
A	 large	 number	 of	 studies	 have	 been	 conducted	 on	 the	
lectins	 isolated	from	E.	 indica,	most	of	which	that	describe	the	
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phytochemical	and	biological	significance	of	E.	indica	have	been	
described.	
Horejsi	et	al.,	isolated	lectins	from	the	seeds	of	B.	frondosa,	
E.	 indica	 and	M.	 charantia	 using	 affinity	 chromatography.	The	
lectin	 from	 E.	 indica	 seeds	 were	 reported	 to	 have	 a	
sedimentation	 coefficient	 s20,	w	=	4.0	 S,	 its	molecular	weight	
was	66,200,	and	it	was	found	to	consist	of	two	subunits	having	
molecular	weights	30,000	and	34,000,	 respectively.	The	 lectin	
is	devoid	of	cysteine,	has	a	neutral	sugar	content	of	5.6%,	and	
glucosamine	content	of	0.46%.	the	lectin	probably	contains	one	
Mn	atom	per	subunit,	and	the	N‐terminal	amino	acid	sequence	
is	Val‐Glu‐Val‐Leu‐(Phe)‐Phe‐(Ala)‐Phe‐	[31].	
Bhattacharyya	et	al.,	 isolated	lectins	from	the	seeds	of	four	
species	of	the	genus	Erythrina	by	affinity	chromatography.	The	
SDS‐gel	 electrophoresis	 showed	 that	 E.	 indica	 produced	 two	
bands	 with	 subunit	 having	 molecular	 weights	 26,000	 and	
28,000.	The	lectins	exhibited	a	neutral	sugar	contents	between	
4‐9%.	 E.	 indica	 lectins	 indicated	 higher	 hemagglutinating	
activity	toward	the	erythrocytes	of	O	group	[32].	
In	 a	 comparitive	 study	 of	 certain	 physicochemical	 and	
structural	properties	of	the	lectins	from	the	seeds	of	the	genus	
Erythrina,	 it	was	noted	that	E.	indica	possess	higher	quantities	
of	acidic	and	hydroxy	amino	acids	and	low	quantities	of	sulphur	
containing	 amino	 acids,	 and	 possess	 valine	 as	 the	 only																
N‐terminal	 amino	 acid.	 E.	 indica	 lectins	 are	 glycoproteins	
containing	 higher	 quantities	 of	 mannose	 type	 complex	
oligosaccharide	 chains,	 and	 also	 contain	 arabinose,	 xylose,	
fucose,	 glucose,	 and	 galactose.	E.	 indica	 lectins	 bind	 to	Con‐A‐
Sepharose	 but	 not	 with	 lentil	 or	 pea	 lectin‐Sepharose,	 thus	
indicating	the	presence	of	terminal	non‐reducing	α‐D‐mannose	
and/or	internal	2‐O‐α‐linked	mannose	residues	in	these	lectins,	
and	the	absence	of	α(1→6)	linked	L‐fucose	residues	in	the	core	
regions	of	the	oligosaccharide	units	[33].	
Bhattacharyya	and	Brewer,	investigated	the	interactions	of	
the	 oligosaccharide	 with	 E.	 indica	 leaf	 by	 quantitative	
precipitation	analysis.	The	equivalence	point	of	the	precipition	
curve	 indicated	 that	 the	 glycopeptide	 is	 trivalent	 for	E.	 indica	
leaf	 binding.	 	 Thus	 it	 was	 suggested	 that	 each	 arm	 of	 the	
oligosaccharide	 could	 independently	 be	 bound	 to	 separate	
lectin	molecules	and	lead	to	precipitation	of	the	complex	[34].	
Sudakevitz	 et	 al.,	 purified	 lectins	 from	 certain	 Erythrina	
species	and	detected	their	capacity	for	H/HI	blood	groups.	The	
reactions	 of	 E.	 indica	 lectins	 with	 erythrocytes	 of	 different	
ABO(H)	 and	 Ii	 blood	 groups	 showed	 the	 following	 order	 of	
activity:	 O(H)I	 >	 A2I	 >	 O(H)i	 adult	 >	 A2BI	 >	 BI	 >	 O(H)i	 cord	
>A1I	>	A1i	adult	>	Bi	cord	>	A1BI	>	Ai	cord	>	ABi	cord	>	OhI.	
Furthermore	 the	 lectin	 of	 E.	 indica	 indicated	 a	 lower	
differentiation	 between	 the	 agglutination	 of	 O(H)	 and	 Oh	
erythrocytes	[35].	
Mandal	and	Brewer,	examined	the	capacities	of	the	14‐kDa	
β‐galactoside‐specific	 lectin	 from	 calf	 spleen,	 a	 dimeric	 S‐type	
animal	 lectin,	 and	 certain	 galactose‐specific	plant	 lectins	 from	
three	plants	including	E.	indica,	to	produce	specific	cross‐linked	
complexes	with	asialofetuin,	the	formation	was	compared	using	
quantitative	 precipitation	 analyses.	 The	 two	 dimeric	 lectins	
from	E.	 indica	 formed	1:9	and	1:3	stoichiometric	asialofetuin	‐
lectin	cross‐linked	complexes	[36].	
Bhattacharyya	and	Brewer,	showed	that	Gal‐specific	lectins	
from	 E.	 indica	 and	 Ricinus	 communis	 produce	 homogeneous	
crosslinked	complexes	with	individual	carbohydrates	in	binary	
mixtures	 of	 triantennary	 and	 tetraantennary	 complex‐type	
oligosaccharides	with	 terminal	 Gal	 residues.	 	 Binary	mixtures	
of	 Gal/GalNAc‐specific	 lectins	 from	 E.	 indica,	 in	 the	 presence	
branched‐chain	 oligosaccharide	 with	 terminal	 GalNAc	 or	 Gal	
residues	 indicate	 the	 production	 of	 separate	 crosslinked	
lattices	between	each	lectin	and	the	carbohydrate	[37].	
Gupta	 et	al.,	 studied	 the	 thermodynamics	 of	 carbohydrate	
binding	 to	 the	 14‐kDa	 dimeric	 β‐galactoside‐binding	 lectin	
galectin‐1	 (Gal‐1)	 from	 Chinese	 hamster	 ovary	 cells	 and	 four	
galactose‐specific	 plant	 lectins	 (including	 E.	 indica).	 The	 E.	
indica	 lectins	 indicated	 greater	 affinities	 and	 ‐ΔH	 values	 for	
lactose	and	N‐acetyllactosamine	[38].	
Konozy	et	al.,	isolated	lectin	from	the	leaves	of	E.	indica	by	
affinity	 chromatography.	 In	 SDS‐gel	 electrophoresis	 under	
reducing	 and	non‐reducing	 conditions	 the	 isolated	 lectin	 split	
into	 two	bands	with	 subunit	 having	 a	molecular	weight	 of	 30	
and	33	kDa,	and	the	weight	of	the	intact	lectin	obtained	by	gel	
filtration	 was	 found	 to	 be	 58	 kDa.	 E.	 indica	 leaf	 lectin	
agglutinated	all	human	RBC	types,	with	a	slight	preference	for	
the	 O	 blood	 group.	 	 Lectin	 was	 found	 to	 be	 a	 glycoprotein	
having	 a	 neutral	 sugar	 content	 of	 9.5%.	 	 E.	 indica	 leaf	 lectin	
exhibited	optimum	pH	7.0;	above	and	below	this	pH	lectin	lost	
sugar‐binding	 capacity.	 	 Lectin	 exhibited	 broad	 temperature	
optima	from	25	to	50	oC;	but,	at	55	oC	the	lectin	lost	more	than	
90%	of	 its	activity	and	at	60	oC	 it	became	completely	 inactive.		
The	 lectin	 was	 found	 to	 be	 abundant	 in	 acidic	 as	 well	 as	
hydrophobic	 amino	 acids	 and	 completely	 lacked	 cysteine	 and	
methionine	[39].	
Kestwal	et	al.,	 isolated	a	glycoprotien	α‐mannosidase	from	
the	seeds	of	E.	indica	and	purified	it	(26‐times)	to	homogeneity	
by	gel	filtration	by	Bio‐Gel	P‐100	and	affinity	chromatography.	
The	molecular	weight	 of	α‐mannosidase	was	 found	 to	be	124	
and	127	kDa	by	gel	 filtration	and	SDS‐PAGE,	 respectively.	The	
optimum	pH	and	temperature	for	enzyme	activity	were	 found	
to	be	4.6	and	50	oC,	respectively.		The	Km	of	the	enzyme	for	p‐
nitrophenyl‐β‐D‐mannopyranoside	was	2.1	mM,	and	its	activity	
was	found	to	depend	on	the	presence	of	Zn2+	[40].	
Kestwal	 et	 al.,	 isolated	 the	 enzyme	 α‐mannosidase	 from	
Erythrina	indica	seeds	and	tested	it	for	certain	properties.	This	
enzyme	 is	 reported	 to	 be	 Zn2+	 dependent	 glycoprotein	 with	
8.6%	carbohydrate;	it	has	a	temperature	optimum	of	50	°C	and	
energy	 of	 activation	 23	kJ/mol.	 The	 chemical	 modification	
studies	 showed	 that	 the	 treatment	 of	 the	 enzyme	 with	 N‐
bromosuccinimide	 (NBS)	 led	 to	 total	 loss	 of	 enzyme	 activity,	
while	the	modification	of	a	single	tryptophan	residue	led	to	the	
inactivation	of	 the	enzyme.	Fluorescence	studies	with	 in	 a	pH	
range	 of	 3–8	 have	 indicated	 tryptophan	 residue	 to	 be	 in	 a	
highly	hydrophobic	 environment	 and	pH	change	was	not	 able	
to	 alter	 the	environment.	An	α‐helical	 structure	was	observed	
by	Far‐UV	CD	spectrum	and	α‐mannosidase	from	E	 indica	was	
found	 to	 be	 immunological	 identitical	 to	 the	 α‐mannosidase	
from	Canavalia	ensiformis	but	not	with	those	from	Glycine	max	
and	 Cicer	 arietinum.	 A	 35%	 increase	 in	 enzyme	 activity	 was	
observed	by	incubating	the	E.	indica	lectin	with	α‐mannosidase,	
but	no	such	activation	was	observed	for	acid	phosphatase	from	
E.	indica.	The	Lectin	induced	activation	of	α‐mannosidase	could	
be	lost	in	presence	of	lactose	[41].	
Kestwal	et	al.,	isolated	an	enzyme	β‐galactosidase	from	the	
seeds	of	E.	indica,	and	prepared	a	homogeneous	solution	of	the	
enzyme	 by	 ion‐exchange	 chromatography	 followed	 by	 gel	
filtration,	 the	 enzyme	 was	 also	 tested	 for	 certain	 properties.	
The	 enzyme	 appeared	 to	 be	 a	 dimmer,	 and	 its	 molecular	
weights	 by	 gel	 filtration	 and	 SDS‐PAGE,	were	 found	 to	 be	 74	
kDa	 and	 78	 kDa,	 respectively.	 The	 optimum	 pH	 and	
temperature	 for	 enzyme	 activity	 were	 4.4	 and	 50	 oC,	
respectively.		The	enzyme	indicated	a	Km	value	of	2.6	mM	and	
Vmax	of	3.86	U/mg	for	p‐nitrophenyl‐β‐D‐galactopyranoside	as	
substrate	and	was	 inhibited	by	Zn2+	and	Hg2+.	Enzyme	activity	
was	regulated	by	feedback	 inhibition,	since	 it	was	found	to	be	
inhibited	 by	 β‐D‐galactose.	 Chemical	 modification	 studies	
showed	a	role	of	tryptophan	and	histidine	for	enzyme	activity,	
the	 role	 of	 tryptophan	was	 confirmed	by	 fluorescence	 studies	
and	 one	 tryptophan	was	 indicated	 to	 be	present	 in	 the	 active	
site	 of	 β‐galactosidase.	 	 Circular	 dichroism	 examinations	
indicated	 37%	 α‐helix,	 27%	 β‐sheet	 and	 38%	 random	 coil	 in	
the	secondary	structure	of	the	purified	enzyme	[42].	
	
5.	Biological	activities	and	formulations	
	
5.1.	Antibacterial	and	antifungal	
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Bhale	 et	 al.,	 examined	 activity	 of	 the	 seed	 oil	 of	 E.	 indica	
against	 ten	bacterial	and	ten	 fungal	strains.	The	oil	was	 found	
to	be	more	active	than	penicillin	and	streptomycin,	and	potent	
activity	 was	 observed	 against	 the	 other	 tested	 bacterial	 and	
fungal	strains	[43].	
Singh	et	al.,	studied	the	effects	of	D‐galactose‐binding	lectin	
isolated	 from	 E.	 indica	 on	 the	 eggs	 and	 larvae	 Bactrocera	
cucurbitae.	 	 The	 various	 concentrations	 of	 lectin	 (0,	 125,	 250,	
500,	and	1000	μg/mL)	did	not	show	any	significant	reduction	
in	 percent	 hatching	 of	 eggs.	 	 However,	 percent	 pupation	was	
significantly	reduced	[44].	
	
5.2.	Adenosinetriphosphatase	inhibitory	activity	
	
Nguyen	 et	 al.,	 reported	 the	 aqueous	 alkaloid	 extracts	 of	
Ziziphus	 jujuba,	 Nelumbo	 nucifera,	 and	 E.	 indica	 to	 exhibit	
adenosinetriphosphatase	 inhibitory	 activity	 in	 rat	 brain	
membranes	[45].	
	
5.3.	Antioxidant	activity	
	
Moon	et	al.,	examined	the	methanolic	extracts	E.	indica	bark	
for	DPPH	free	radical	scavenging	activity,	reducing	power	and	
nitric	 oxide	 scavenging	 activity,	 as	 well	 as	 the	 total	 phenolic	
content.	 E.	 indica	 was	 found	 to	 exhibit	 potent	 antioxidant	
activity	[7].	
Sakat	 and	 Juvekar,	 examined	 the	 aqueous	 and	methanolic	
extracts	of	 the	 leaves	of	E.	 indica,	using	 in	vitro	methods	such	
as:	 1,1‐Diphenyl‐2‐Picrylhydrazyl,	 nitric	 oxide	 radical	
scavenging	 activity,	 and	 inhibition	 of	 lipid	 peroxidation	 by	
thiobarbituric	 acid	 reactive	 substances	 (TBARS)	 method	 on	
isolated	 rat	 liver	 tissues.	 The	 study	 also	 quantified	 the	
antioxidative	 constituents	 such	 as:	 total	 phenolics,	 flavonoids,	
and	 flavonols	 using	 spectrophotometric	 method.	 The	 IC50	
values	for	the	aqueous	and	methanolic	extracts	for	the	various	
tests	 were	 as	 follows:	 DPPH	 radicals	 scavenging	 activity	
(342.59	 ±	 19.59	 and	 283.24	 ±	 12.28	 μg/mL),	 nitric	 oxide	
radical	scavenging	activity	(250.12	±	10.66	and	328.29	±	3.74	
μg/mL),	 lipid	peroxidation	 induced	by	the	Fe2+	(283.74	±	5.70	
and	 97.29	 ±	 2.05	 μg/mL).	 The	 total	 flavonoids	 and	 flavonols	
were	found	to	be	higher	in	the	aqueous	extract,	while	the	total	
phenolics	content	was	equal	in	both	the	extracts.	According	to	
the	study	the	presence	of	flavonoids	and	polyphenolics,	may	be	
responsible	for	the	good	antioxidant	activity	of	E.	indica	[10].	
	
5.4.	Fat	lowering	formulation	
	
A	fat	absorption	formulation	was	prepared	from	a	group	of	
medicinal	 plants	 including	 the	 cortex	 of	 E.	 indica.	 The	
formulation	 is	 claimed	 to	 possess	 fat,	 lipase	 and	 obesity	
inhibitory	 properties,	 it	 is	 also	 suggested	 to	 reduce	
hypertriglyceridemia	[46].	
	
5.5.	Health	care/enhancing	formulations	
	
A	 suppository	 was	 prepared	 from	 a	 group	 of	 plants	
including	E.	 indica,	 the	suppositories	were	mixed	with	various	
oils	 such	 as	 cocoa	 butter,	 olive	 oil,	 soybean	 oil,	 vegetable	 oil,	
other	 hydrogenate	 fatty	 acids,	 petrolatum,	 various	 forms	 of	
paraffin,	 stearic	 acid	 and	 oleic	 acid	 to	 produce	 oil‐based	
suppositories.	 The	 suppositories	 were	 also	 mixed	 with	
polymers	 glycerinated	 gelatine	 and	 polysorbate	 to	 produce	
aqueous	based	suppositories.	The	suppositories	are	claimed	to	
treat	 infections	 of	 upper	 the	 respiratory	 tract,	 and	 undesired	
symptoms	 from	 allergic	 rhinitis,	 sinusitis,	 nasal	 congestion,	
nasal	dripping,	nasal	polyps,	infections,	fevers,	coughs,	spasms,	
dizziness	and	convulsions	[47].	
Two	 formulations	 were	 prepared	 from	 a	 group	 of	 plants	
including	E.	 indica;	 one	 formulation	was	 found	 to	be	 effective	
against	 sarafotoxins	 present	 in	 snake	 venom.	 The	 other	
formulation		is	claimed	to	induce	apoptosis	[48,49].	
A	 composition	 for	 a	 liniment	 was	 prepared	 by	 mixing	
sodium	 hyaluronate,	 polyvinyl	 alcohol,	 ethanol,	 p‐
hydroxybenzoate,	and	 the	 liquid	extracts	of	certain	 traditional	
Chinese	 medicinal	 plants	 including	 E.	 indica.	 The	 liniment	
produced	 is	 claimed	 to	 be	 effective	 in	 foot	 care	 of	 patients	
suffering	from	diabetes	[50].	
Cotton	product	was	formulated	by	mixing	a	group	of	plants	
including	 E.	 indica	 and	 certain	 other	 constituents	 such	 as:	
impregnant	 liquid,	 orpiment,	 sulphur	 and	 burkeite.	 The	
mixture	 is	 decocted	with	water,	 filtered	 and	 soaked	 in	 cotton	
and	dried	in	a	dark	place.	The	product	can	be	used	for	making	
health‐care	pillows	and	cushions	[51].	
A	medicated	 bag	was	 produced	 from	 a	 group	 of	 plants	 in	
including	 E.	 indica,	 by	 decocting	 the	 plant	materials	 in	 water	
followed	 by	 drying	 in	 sunlight,	 pulverizing	 and	 filling	 in	 a	
cotton	bag.	The	medicated	bag	after	steam	heating	can	be	used	
hot	compress	therapy.	It	is	suggested	to	possess	effects	such	as	
relaxing	 muscles	 and	 tendons,	 reliving	 cold	 and	 removing	
toxins.		It	is	also	suggested	to	treat	rheumatic	arthritis,	cervical	
spondylosis,	lumbar	spondylosis,	scapulohumeral	periarthritis,	
sciatica,	lumbar	strain,	sprain	and	contusion	[52].	
A	 composition	 for	 a	 foot	 bath	 powder	 was	 developed	 by	
grinding	Chinese	medicinal	plant	materials	 including	E.	 indica	
and	 mixing	 with	 sodium	 polyacrylate.	 The	 use	 of	 the	
composition	 is	 suggested	 to	 prevent	 diseases	 by	 stimulating	
acupoints,	balancing	yin	and	yang,	tranquilizing	mind,	reducing	
blood	 viscosity,	 blood	 lipid	 and	 blood	 cholesterol	 levels,	
increasing	 immunity,	 relaxing	 tendons,	 activating	 collateral	
flow	and	relieving	fatigue	[53].	
An	 oral	 solution	 for	 a	 Chinese	medicine	 composition	was	
developed	from	a	group	of	plants	in	including	E.	indica	bark,	by	
decocting	 the	 plant	 material	 in	 water	 followed	 by	 vacuum	
packing	to	produce	an	oral	solution.		The	solution	is	suggested	
to	 possess	 heat	 clearing,	 dampness	 and	 channel	 blockage	
reducing	 properties.	 It	 can	 also	 be	 used	 for	 treating	 warm	
numbness,	joint	pain,	chlorosis	in	face	and	eyes	and	scanty	dark	
urine	[54].	
	
5.6.	Pain	relieving	formulations	
	
Boddupalli	 et	 al.,	 developed	 a	 composition	 from	 a	 plant	
selected	 from	 a	 group	 of	 plants	 including	 E.	 indica.	 	 The	
composition	 is	 suggested	 to	 treat	 or	 regulated	 bone	 and	 joint	
conditions	such	as	joint	inflammation,	joint	swelling,	joint	pain,	
gout,	 childhood	 arthritis,	 lupus	 arthritis,	 rheumatoid	 arthritis,	
and	osteoarthritis	[55].	
A	 preparation	 for	 a	 Chinese	 medicine	 composition	 was	
developed	from	a	group	of	plants	in	including	Erythrina	indica.	
The	 composition	 is	 suggested	 to	 be	 used	 for	 eliminating	
hemorrhage	 and	 diarrhea	 as	well	 as	 treating	 pains	 caused	 by	
periarthritis	 humeroscapularis,	 arthritis,	 convulsion,	 fatigue	
and	wounds	[56].	
A	 preparation	 for	 a	 tincture	 and	 a	 plaster	was	 developed	
from	 a	 group	 of	 in	 including	 Erythrina	 indica,	 the	 tincture	 is	
claimed	 to	 treat	 scapulohumeral	 periarthritis,	 arthralgia,	
rheumatalgia,	hyperosteogeny,	soft	tissue	injury	and	traumatic	
injury.	 The	 plaster	 is	 suggested	 to	 treat	 traumatic	 injury	 and	
rheumatic	diseases	[57,58].	
Han,	 developed	 a	 method	 for	 the	 preparation	 of	 Chinese	
medicinal	 spray	 from	 a	 group	 of	 plants	 including	 Erythrina	
indica.	 The	 solution	 was	 prepared	 by	 soaking	 the	 plants	
material	for	24‐hours	followed	by	decocting	the	mixture	fir	half	
an	 hour	 to	 yield	 a	 concentrated	 solution,	 finally	 borneol	 was	
added	to	the	solution.	The	spray	is	suggested	to	be	absorbed	by	
transdermal	 osmosis	 and	 possess	 anti‐inflammatory	 and	
analgesic	effects	[59].	
	
5.7.	Skin	whitening	formulation	
	
Kimura	and	Takayama,	developed	a	skin	preparation	from	
a	plant	selected	from	a	group	of	plants	including	E.	indica.		The	
Amir	et	al.	/	European	Journal	of	Chemistry	2	(4)	(2011)	561‐565	 565	
 
formulation	 is	 suggested	 to	 possess	 Maillard	 reaction	
inhibitory,	collagen	bridging,	skin	whitening,	wrinkle	reduction	
and	anti‐aging	properties	[60].	
	
6.	Conclusion	
	
The	present	review	describes	the	significance	of	E.	indica	as	
an	 important	 medicinal	 plant	 exhibiting	 diverse	 biological	
activities.	 Since	 the	 number	 of	 phytochemical	 constituents	
identified	 from	 the	 E.	 indica	 is	 limited	 it	 would	 be	 a	 rich	
opportunity	 to	 isolate	 more	 bioactive	 chemical	 constituents.	
For	 this	 plant,	 furthermore,	 it	 would	 also	 be	 valuable	 to	
determine	 the	 structure	 activity	 relationship	 of	 the	 identified	
compounds.	
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